Tag: Covid Vaccine

It was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for full vaccination, said Adar Poonawalla on Friday

The study was conducted on at least 40,000 elderly people in Argentina. Sputnik Light also reduced hospitalizations among the target population at 82.1-87.6 per cent, the study said.

The findings showed that the currently available Covid-19 jabs provide strong protection for most people against hospitalisation and death, even during the delta surge. However, higher hospitalisation and death rates are observed in older age groups, regardless of vaccination status.

Almost 20-25 percent of fully inoculated population would not develop antibodies for Covid-19. This information was shared by Director of Institute of Life Sciences (ILS), Ajay Parida on Saturday (Sept 11).

The global health body is currently reviewing Bharat Biotech's application for an Emergency Use Listing of its COVID-19 vaccine Covaxin.

Moderna is developing vaccines against viral diseases including vaccines against acute respiratory infections, vaccines against persistent infections, as well as vaccines against threats to global public health.

The MHRA also noted that it is now up to the Joint Committee on Vaccination and Immunisation (JCVI), the UK vaccine advisory body, "to advise on whether booster jabs will be given and if so, which vaccines should be used".

The incidence of the side effect remains extremely rare, with only 833 cases reported worldwide from about 592 million administered doses of the adenovirus-based AstraZeneca vaccine, as of July 25.

Cumulatively, 27,64,10,694 people in the 18-44 age group have received their first dose and 3,57,76,726 the second dose since the start of Phase-3 of the vaccination drive.

Biological E has received the Drugs Controller General of Indias' (DCGI) approval for conducting Phase 3 comparator safety and immunogenicity trial of its Corbevax vaccine in adults after the subject expert committee's (SEC) review of Phase 1 and 2 clinical trials data.

India's vaccination coverage against coronavirus under the mass vaccination drive has crossed the landmark of 63 crore. Over 73 lakh doses have been administered in the last 24 hours.

The antibody responses of individuals with confirmed pre-vaccination SARS-CoV-2 infection were compared with those individuals without prior evidence of infection.

Gennova submitted the proposed Phase 2 and 3 study titled 'A Prospective, Multicentre, Randomised, Active-controlled, Observer-blind, Phase II study seamlessly followed by a Phase III study to evaluate the Safety, Tolerability, and Immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy subjects' which was approved by the office of the DCGI, CDSCO.

A study showed a robust antibody response in blood and breast milk of lactating mothers vaccinated against Covid-19, which may help protect nursing infants from the illness

Among some people with weak immune systems, the response of two doses of Covid vaccine remains low or absent, according to a study.